Nanobodies: natural single-domain antibodies.
By S. Muyldermans. 2013
2,047 citations recorded by the source corpus.
Subfields: Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
- A. Kruse
- Conor McMahon
- A. Manglik
- Jung-Eun Shin
- Debora Marks
- Adam J. Riesselman
- Christopher Sander
- Aaron W. Kollasch
In Molecular Biology
- Debora Marks
- Christopher Sander
- Adam J. Riesselman
- A. Kruse
- Conor McMahon
- Jung-Eun Shin
- A. Manglik
- Elana Simon
In Radiology, Nuclear Medicine and Imaging
- A. Kruse
- Conor McMahon
- A. Manglik
- Jung-Eun Shin
- Debora Marks
- Adam J. Riesselman
- Christopher Sander
- Aaron W. Kollasch
Citations in the corpus
- Accelerating Protein Design Using Autoregressive Generative Models (2019, background): “These sequences contain four highly conserved framework regions interspersed with three variable length, hypermutated complementarity determining regions (CDRs), which makes high-confidence alignments difficult to construct (Muyldermans, 2013).”
- Antibody Structure and Function: The Basis for Engineering Therapeutics (2019, background): “The VHH domain structure lacks the human or mouse mAb HC-LC structure (which are hydrophobic at their pairing interface), resulting in a surface that is much more hydrophilic than that of an IgG Fab region [298,299].”
- Exploiting sequence and stability information for directing nanobody stability engineering (2017, background): “A general feature of nanobody sequences is their preferential use of more polar residues at four, so-called hallmark positions, which establish the binding to the light chain variable domain (VL) in conventional binders [5] (MSA numbering: positions 40, 47, 49 and 51; Kabat numbering: positions 37, ”
- Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice (2021, neutral): “Nanobodies are ∼ 12 to 15 kDa in size, highly stable across a wide range of pH and temperature, display strong binding affinities to target proteins, and can be expressed with high yields in bacterial, yeast, and mammalian expression systems (27, 28).”
- Protein design and variant prediction using autoregressive generative models (2021, background): “Antibodies are valuable tools for molecular biology and therapeutics because they can detect low concentrations of target antigens with high sensitivity and speci fi city 6 .”